PARTICIPANT: If you go on to the Department of Health in London's Web site, there is a public information leaflet that tells you and your family what you need to know about pandemic flu. The point about this is that this has been researched. And just as it is important to be doing the research on all of the things we have heard about in the last two days, this simple piece of writing and leaflet has been researched with the public. It is been redrafted and re-researched. This is part of the operational research and the infrastructure research that is every bit as important as the rest of the science. If you cannot communicate the issues, there is not much point to actually doing the science. So, we already have this communication piece. It is in place, and it is available. But this type of research is a part of the research agenda that we have not talked about in the last two days. It is every bit as important.

DR. FINEBERG: Thank you for that reinforcement. This has been a remarkably hardworking group. I must say, the fact that you have been willing to attend so faithfully not only the plenary sessions, but to throw yourselves into the workshops to work so creatively, I would say so abundantly with the ideas that will give us a lot to work with in trying to craft the proceedings of this discussion that does justice not only to the ideas, but to the convictions and the drive that is behind so much of this discussion.

I think that it is inevitable that a research strategy must begin from a vantage point of asking why we are starting on this research. And if we do that, and if we start from a vantage point of protecting the public, if we start from a vantage point of protecting the individual patient, if we start from a vantage point of solving mysteries of biology that apply to flu and to others, if we ask ourselves the question of what is important in one country, and what is important from another country's vantage point.

If we are willing to take multiple perspectives, I think we are going to be able to define a convergent research strategy that is going to depend upon many actors working in a way, at a degree of coherence, and a degree of collaboration, and a degree of coordination that is unprecedented in the flu field, and maybe unprecedented in preparation in advance for any natural disaster. I am hopeful that this deliberation, this set of discussions can contribute materially to the ability of ourselves, our nation, our world to accomplish that kind of increased coherence for research.

I want to ask each of you who are here if you have thoughts afterward that are result of further reflection, or perhaps you have not felt moved to come to a microphone, and would like to share some additional ideas bearing on these questions that we have discussed over the two days, we welcome them. We urge you to share them.

I want to say personally how much of a thrill it is been for me to be able to be part of the discussions, to be with so many who have done so much over such a long time for public health, for influenza, for research, for the care of patients, for the advancement of science as it bears on all of these concerns. I am truly grateful to all of you for your participation. I want to thank the presenters, the briefers, the chairs, the rapporteurs, and all those who have contributed so much through the course of these discussions, and helping to plan it, and helping to carry it through.

I look forward very much to our continued work together toward the goals that we have outlined. I want to thank all of you for being part of the program. And please join me in also thanking especially the staff, Dr. Rose Marie Martinez and others who have been so valuable through the course of these days in making our discussions come to life.



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement